The global Viral and Non-Viral Vector Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Viral and Non-Viral Vector Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral and Non-Viral Vector Manufacturing. This report contains market size and forecasts of Viral and Non-Viral Vector Manufacturing in global, including the following market information:
- Global Viral and Non-Viral Vector Manufacturing Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Viral Vectors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Viral and Non-Viral Vector Manufacturing include Boehringer Ingelheim, Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica Plc and Sartorius AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Viral and Non-Viral Vector Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Viral and Non-Viral Vector Manufacturing Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, by Type, 2022 (%)
- Viral Vectors
- Non-Viral Vectors
Global Viral and Non-Viral Vector Manufacturing Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, by Application, 2022 (%)
- Gene Therapy
- Vaccinology
- Cell Therapy
- Others
Global Viral and Non-Viral Vector Manufacturing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Viral and Non-Viral Vector Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Viral and Non-Viral Vector Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Viral and Non-Viral Vector Manufacturing revenues share in global market, 2022 (%)
key players include:
- Boehringer Ingelheim
- Catalent, Inc.
- FUJIFILM Holdings Corporation
- Danaher Corporation
- Genscript Biotech Corporation
- Lonza Group AG
- Merck KGaA Inc.
- Oxford Biomedica Plc
- Sartorius AG
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Wuxi AppTec
- Acuitas Therapeutics
- Evonik Industries AG
- Exelead, Inc.
- Entos Pharmaceuticals
- Genevant Sciences GmbH
- T&T Scientific Corporation
- Moderna, Inc.
- CureVac N.V.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Viral and Non-Viral Vector Manufacturing, market overview.
Chapter 2: Global Viral and Non-Viral Vector Manufacturing market size in revenue.
Chapter 3: Detailed analysis of Viral and Non-Viral Vector Manufacturing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Viral and Non-Viral Vector Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
